Temporal profile of vascular changes induced by systemic nitroglycerin in the meningeal and cortical districts.
BACKGROUND
Clinical studies indicated that nitric oxide (NO) donors cause regional changes in cerebral blood flow (CBF), similar to those reported in spontaneous migraine. Systemic nitroglycerin (NTG), a NO donor, is a well-accepted experimental model of migraine. In this study we have examined the effects of NTG on the meningeal and cortical blood flow in rats.


METHODS
Regional blood flow was monitored in male Sprague-Dawley rats using laser Doppler flowmetry before and after NTG/saline injection over 150 minutes. The effect of pre-treatment with Nω-nitro-L-arginine ester (L-NAME) or 7-nitroindazole (7-NI) on NTG-induced changes on blood flow was also investigated.


RESULTS
In the dura NTG caused a biphasic response represented by an initial decrease in blood flow followed by a significant increase. At variance, in the cortex NTG caused only an increase in blood flow. Pre-treatment with either L-NAME or 7-NI prevented NTG-induced increase in blood flow in both districts, while only L-NAME also prevented NTG-induced decrease in dural blood flow.


CONCLUSIONS
The present findings provide additional information on the timing of effects of NTG on blood flow at both the meningeal and cortical levels. These effects seem to be related to vasoregulatory mechanisms and/or metabolic activity in response to the synthesis of endogenous NO.
Greco
Rosaria
R
IRCCS National Neurological Institute C. Mondino Foundation, Pavia, Italy. rosaria.greco@mondino.it
Meazza
Cristina
C
Mangione
Antonina Stefania
AS
Allena
Marta
M
Bolla
Monica
M
Amantea
Diana
D
Mizoguchi
Hirocazu
H
Sandrini
Giorgio
G
Nappi
Giuseppe
G
Tassorelli
Cristina
C
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002540:Cerebral Cortex / Q000098:blood supply; D002560:Cerebrovascular Circulation / Q000187:drug effects* / Q000502:physiology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D007191:Indazoles / Q000494:pharmacology; D008297:Male; D008576:Meningeal Arteries / Q000187:drug effects* / Q000502:physiology; D008578:Meninges / Q000098:blood supply; D008881:Migraine Disorders / Q000503:physiopathology*; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D005996:Nitroglycerin / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D014664:Vasodilation / Q000187:drug effects / Q000502:physiology; D014665:Vasodilator Agents / Q000494:pharmacology*
D004791:Enzyme Inhibitors; D007191:Indazoles; D014665:Vasodilator Agents; D005996:Nitroglycerin; C080122:7-nitroindazole; D019331:NG-Nitroarginine Methyl Ester